Expression of meningococcal fhbp polypeptides

Details for Australian Patent Application No. 2010302344 (hide)

Owner Novartis AG

Inventors Oriente, Francesca; Delany, Isabel

Agent FB Rice

Pub. Number AU-A-2010302344

PCT Pub. Number WO2011/039631

Priority 61/247,428 30.09.09 US

Filing date 30 September 2010

Wipo publication date 7 April 2011

International Classifications

C07K 14/22 (2006.01) Peptides having more than 20 amino acids

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 39/095 (2006.01) Medicinal preparations containing antigens or antibodies - Neisseria

C12N 15/67 (2006.01) Mutation or genetic engineering - General methods for enhancing the expression

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Event Publications

26 April 2012 PCT application entered the National Phase

  PCT publication WO2011/039631 Priority application(s): WO2011/039631

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010302349-Determining establishment causes for emergency sessions

2010302312-Advancing assembly and powered shield support herewith